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Background
Microspheres, a potential drug delivery system in the segment of novel drug delivery, 
are defined as structure made up of continuous phase of one or more miscible polymers 
in which drug particles are dispersed at the molecular or macroscopic level. Generally 
the size of the microencapsulated products (micro-particles) is considered as larger 
than 1–1000 μm in diameter (Parida et al. 2008). Among the several different methods 
of microencapsulation the most common are solvent evaporation, coacervation, coa-
lescence and phase separation, interfacial polymerization, spray drying and ionotropic 
gelation. Solvent-evaporation method engages emulsification of a solution of polymer 
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The aim of the current study was to formulate Fexofenadine hydrochloride loaded 
sustained release microspheres using HPMC K100 M CR, a release retardant hydrophilic 
polymer by solvent evaporation method. The effect of different drug loading on drug 
content, drug encapsulation efficiency and release of drug was monitored. The studies 
on in vitro release mechanism were performed using USP paddle method with 900 ml 
of phosphate buffer (pH 6.8) for 10 h at 100 rpm. The mechanism of the drug release 
was determined by fitting in vitro release data to various release kinetic models such 
as the zero order, first order, Higuchi, Hixson Crowell and Korsemeyer–Peppas model 
and finding R2 values for the release profile corresponding to each model. The results 
confirm that the release rate of the drug from the microspheres is highly affected by 
the drug to polymer ratio. The study finds that Higuchi release kinetics, Korsmeyer–
Peppas release kinetics and Hixson–Crowell release kinetics were the major release 
mechanism. The release mechanism was found to be non-Fickian with increase of 
polymer content. Scanning electron microscopic technique was performed to obtain 
the morphological changes due to different drug loading. Differential scanning calo-
rimetry and Fourier transform infra-red spectroscopy was performed to determine any 
interaction of drug with the polymer. A statistically significant variation in release rate 
was observed for variation in the amount of HPMC K100 M CR. In the present study, a 
series of sustained release formulations of Fexofenadine hydrochloride were developed 
with different drug loading so that these formulations could further be evaluated from 
the in vivo studies. The formulations were found to be stable and reproducible.
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and drug with an additional medium in which the drug and polymer cannot dissolve. 
The technique is comparatively uncomplicated and has been used for the formulation 
of microcapsules of a range of compounds using several polymers of different purpose 
(Bolourtchian et al. 2005).
Fexofenadine HCl (FFN) is a second-generation nonsedating histamine H1 recep-
tor antagonist extensively used in seasonal allergic rhinitis. The usual dose for adults is 
60  mg two times a day or 180  mg once a day. The half life of the drug is 14.4  h and 
the oral bioavailability is 30–41 % (Product Information: Allegra reviewed 1/2000). The 
adverse effect was reported to be anaphylaxis and hypersensitivity reactions (Product 
Information: Allegra reviewed 10/2001). As it is under the class III of the biopharmaceu-
tical classification system (BCS), polymers can be used to prolong its duration of action 
in body, thereby increasing the bioavailability. Thus to increase the bioavailability by 
sustaining the action and to reduce the frequency of administration, to lessen adverse 
effects and to improve patient compliance, a controlled release formulation of the drug 
is required. Some extended release matrix tablets of Fexofenadine HCl are available in 
the market, but microspheres offer more consistent drug distribution and reduced dose 
dumping compared to matrix tablets.
This research aimed to develop polymeric microspheres of Fexofenadine HCl using 
HPMC K100 M CR polymer to offer sustained release delivery of the drug to aid in long 
term therapy with high margin of safety. HPMC K100 M CR is a hydrophilic release 
retardant polymerand is extensively studied for encapsulating material to develop con-
trolled release dosage forms. Several researchers have investigated the utilization of 
HPMC K 100 M CR as a polymer to microencapsulate a drug utilizing emulsion solvent 
evaporation technique (Uddin et al. 2013; Raut et al. 2013).
Methods
Materials
Fexofenadine HCl was received as a generous gift from Incepta Pharmaceuticals Ltd. 
HPMC K100 M CR (Evonik Industries, Germany), ethanol (MERCK, Germany), n-hex-
ane (MERCK, Germany), Span 80 (sorbitanmonooleate) (MERCK, Germany), light liq-
uid paraffin (MERCK, Germany), potassium dihydrogen phosphate (MERCK, Germany) 
and dipotassium hydrogen phosphate (MERCK, Germany) were used in this study from 
the indicated sources.
Preparation of microspheres of Fexofenadine HCl with HPMC K100 M CR polymer 
by solvent evaporation technique
The microspheres of Fexofenadine HCl were prepared based on the “emulsion-solvent 
evaporation technique” using HPMC K100 M CR. Ethanol was used as solvent. Span80 
was used as lipophilic surfactant for Fexofenadine HCl water in oil (W/O) type of emul-
sions (Ayon et al. 2014; Raval et al. 2011; Jalil and Nixon 1989).
Formulation design
Total five batches (each of 900 mg) of microspheres, designated as F1–F5 were prepared 
with Fexofenadine HCl (Table 1) using HPMC K100 M CR.
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In vitro characterization of Fexofenadine HCl microspheres
Production yield
The yield (%) was determined by the following equation (El-Kamel et al. 2006):
Determination of drug entrapment efficiency
Ten milligram of accurately weighed microspheres was crushed in a glass mortar-pestle 
and was then suspended in 10 ml of pH 6.8 phosphate buffer solution. After 24 h the 
solution was filtered and the filtrate was assessed for drug content. The drug entrapment 
was calculated using the formula (Patel and Patel 2007):
Micromeritics study
Carr’s compressibility index and Hausner ratio were determined. Bulk density and 
tapped density were measured by a volumetric cylinder. Particles having excellent flow 
properties will have value of Carr’s compressibility index, Hausner ratio and angle of 
repose in the range of 5–10, 1.00–1.11 and 25–30 respectively (Lumay et al. 2012).
Surface morphology study with the help of scanning electron microscope (SEM) analysis
The shape and surface morphology of the microspheres was visualized by scanning elec-
tron microscopy (s-3400 N, Hitachi). The samples were prepared by lightly sprinkling 
the microspheres on a double-sided adhesive tape fixed on aluminum stubs. The stubs 
were then put into an ion sputter coater and coated with platinum in the inert envi-
ronment of argon. After coating, the samples were arbitrarily examined by an electron 
beam to get 3D images of the microspheres. The effects of polymer concentration on the 
microsphere shape, integrity and their drug release pattern were studied.
In vitro dissolution study of Fexofenadine HCl microspheres
The in vitro drug release profile from various formulations of microspheres were per-
formed in a paddle type (Type II) dissolutiona pparatus in simulated intestinal fluid 
(phosphate buffer solution, PBS, pH 6.8) at 100 rpm and temperature was maintained 
fixed at 37  °C. The dissolution process was carried out for 10 h and 10 ml dissolution 
sample from each dissolution media was withdrawn at a predetermined intervals of 
Yield (%) =
Weight ofmicrospheres in grams
Weight of total amount ofmaterials added
× 100




Table 1 Formulation protocol for  the microspheres prepared by  using HPMC K100 M CR 
with different drug loading
Formulation Drug:polymer Drug (mg) Methocel K 100 M CR (mg)
F1 2:1 600 300
F2 1.5:1 540 360
F3 1:1 450 450
F4 1:1.5 360 540
F5 1:2 300 600
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30 min, 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th and 10th h and the release was measured 
by UV spectrophotometric method at 259 nm (Manekar et al. 1992).
Data analysis
To analyze the in  vitro release data various kinetic models were used to describe the 
release kinetics. The zero order rate equation (1) describes the systems where the drug 
release rate is independent of its concentration. The first order equation (2) describes 
the release from system where release rate is concentration dependent. Higuchi (1963) 
described the release of drugs from microspheres as a square root of time dependent 
process based on Fickian diffusion equation (3). The Hixson–Crowell cube root law 
equation (4) describes the release from systems where there is a change in surface area 
and diameter of particles or tablets.
where K0 is zero-order rate constant expressed in units of concentration/time and t is 
the time.
where C0 is the initial concentration of drug and K is first order constant.
where K is the constant reflecting the design variables of the system.
where Qt is the amount of drug released in time t, Q0 is the initial amount of the drug in 
tablet and KHC is the rate constant for Hixson–Crowell rate equation.
Successive fractional dissolution time
To characterize the drug release rate in different experimental conditions, time to release 
25 % drug (T25%), time to release 50 % drug (T50%), time to release 50 % drug (T80%) and 
mean dissolution time (MDT) were calculated from dissolution data.
Statistical analysis
Statistical analysis of the results was performed by using one-way analysis of variance 
(ANOVA) followed by Dennett’s t test for comparisons. The limit of significance was set 
at P < 0.05.
Compatibility studies of drug and polymer within Fexofenadine HCl microspheres
Fourier transform infrared spectrophotometry (FTIR)
The IR spectrum of the pure drug, pure polymer, physical mixture of drug and polymer 
and optimized microsphere formulations were obtained to evaluate the chemical integ-
rity and compatibility of the drug with the polymers in the microspheres.
(1)C = k0t
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Differential scanning calorimetery (DSC)
DSC study was carried out to evaluate the interaction between the drug and the pol-
ymers in the microspheres by using a differential scanning calorimeter (DSC 60, 
Shimadzu).
Results and discussion
Production yield (%) of microspheres
Figure  1 shows that yield did not follow any particular pattern of change with drug 
loading.
The practical production yield was found to be the highest for formulation F4 contain-
ing high viscosity HPMC K100 M CR (40 % drug loading). For microspheres prepared 
with HPMC K100 M CR, the lowest value was found to be 80.45 % for F1 (66.66 % drug 
loading).
Drug entrapment efficiency (%) of microspheres
The entrapment efficiency was determined spectrophotometrically by measuring the 
absorbance at 259 nm using pH 6.8 phosphate buffer solution. As Fig. 1 suggests, entrap-
ment efficiency was found to be minimum for formulation F1 (78.86 %) and maximum 
for formulation F5 90.94 %. It was improved with an increase in polymer concentration 
because a higher amount of polymer was available for cross linking which prevented 
drug diffusion from the microspheres (Panchaxari et al. 2013).
Micromeritics study of microspheres prepared with HPMC K100 M CR
The microspheres exhibited good to excellent flow properties (Table 2). The true density 
and bulk density values were in the range of 0.31–0.47 and 0.27–0.43 g/cm3 respectively. 
The most acceptable flow ability was showed by F3 (50 % drug loading) and the worst 








F1 F2 F3 F4 F5
Yield ( %)
Drug Entrapment 
Efficiency ( % )
Fig. 1 Production yield (%) and drug entrapment efficiency of microspheres
Table 2 Results of micromeritics study of microspheres
Formulation Bulk density (g/ml) Tapped density (g/ml) Carr’s compressibility index Hausner ratio
F1 0.27 0.31 12.90 1.15
F2 0.39 0.43 9.30 1.10
F3 0.44 0.46 4.35 1.05
F4 0.34 0.37 8.11 1.09
F5 0.43 0.47 8.51 1.09
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index and Hausner ratio were found to be in the range of 8.51–12.90 and 1.09–1.15 
respectively. The result inferred that the prepared microspheres possess good to excel-
lent flow properties.
Observation of particle morphology by scanning electron microscope (SEM)
Figure 2 shows that,  maximum microspheres were found to be almost spherically shaped 
when observed with an optical microscope, but when observed by SEM they were found 
to be slightly irregular shape and rough surface which is responsible for the sustained, but 
earlier drug release. The surface morphology of the microspheres (F1–F4) was dependent 
on the concentration of polymers. Microspheres having a higher proportion of polymers 
were found to have a smooth surface due to the availability of more polymers for cross-
linking causing the entrapment of more drug. Batch F1 (66.67 % drug loading), represented 
by Fig. 2a, is the microsphere with a rough and fractured surface. The shape of the micro-
spheres of Batch F5 (33.33 % drug loading), represented by Fig. 2b, is almost spherical and 
the surface of the particles is smoother. There was no significant level of fusion among par-
ticles. Presence of pores or cracks may help releasing the drug since these facilitate the pen-
etration of dissolution medium into the microsphere. Roughness of the surface increases 
the chances of wetting and contact of water with the microsphere than the smoother one 
nature of the surface influences the constancy, quality, integrity and dissolution character-
istics of the microspheres. At high concentration, some of the microspheres were fused to 
each other, which may be due to the presence of higher amount of water, which slowly evap-
orates upon stirring, causing the particles to come in contact with each other.
In vitro dissolution and kinetic studies of Fexofenadine HCl loaded polymeric microsphere
HPMC K 100 M CR polymer was used as the release retardant polymer to prepare Fex-
ofenadine HCl loaded microspheres having drug loading 33.33, 40, 50, 60, 66.66 % with 
the formulation F1, F2, F3, F4 and F5 respectively. After preparation according to for-
mulation shown in the (Table  1), their dissolution studies were carried out in paddle 
method (USP apparatus II) in simulated intestinal fluid (pH 6.8) at 100 rpm at 37 °C. The 
release profile of the formulations was monitored up to 10 h. The rate of drug release 
was found to be inversely related to the amount of HPMC K 100 M CR present in the 
Fig. 2 Scanning electron microscopic view of microspheres. a Formulation F1 (66.67 % drug loading) and  
b formulation F5 (33.33 % drug loading)
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formulations, i.e. the rate of drug release increased with decrease in the polymer con-
tent. Figure 3 shows in vitro release kinetics of five formulations (F1–F5) of Fexofenadine 
HCl microspheres prepared with HPMC K100 M CR: A representing zero order release 
pattern, B showing first order release profile, C giving the Higuchi impact, D charac-
terizing Korsmeyer–Peppas plot and E signifying Hixson–Crowell plot. Among all the 
batches, F1–F5 (Table  1), F5 showed best release retardant property. From Table  3, it 
can be inferred that the percent release of drug after 10 h was 85.31 % from F5, showing 
the highest release retarding property. Best fitted model for this formulation were Higu-
chi (R2 =  0.990), Korsmeyer–Peppas (R2 =  0.985) and Hixson–Crowell (R2 =  0.978). 
F1 showed least release retardant property. After dissolution of microsphere the per-
cent release of drug after 10 h was 85.31 % from F1. First order (R2 = 0.983), Higuchi 
































































































































































Fig. 3 In vitro release kinetics of five formulations (F1–F5) of Fexofenadine HCl microspheres prepared with 
HPMC K100 M CR. a Zero order release, b first order release, c Higuchi plot, d Korsmeyer–Peppas plot, e 
Hixson–Crowell plot
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fit best to F1. F1–F3 followed Fickian transport and F4–F5 followed non-Fickian trans-
port (Table 4).
Successive fractional dissolution time
Successive fractional dissolution time was observed to be highest for F5 and lowest for 
F1 (Fig. 4).
Analysis of impact of % drug loading on different formulation
Table 5 reveals that, decrease in drug loading has no significant effect on % yield but has 
significant increasing effect on % drug entrapment efficiency. The time required for 50 % 
of drug release (T50%) increases with increase in the total amount of HPMC K100 M CR 
(decrease in drug loading). Statistically it shows that, with increase in the total amount 
Table 3 Release rate constants and R2 values for different release kinetics of five formula-
tions (F1, F2, F3, F4 and F5) of Fexofenadine HCl microspheres





2 n KKP R
2 KHC R
2
F1 7.378 0.920 −0.187 0.983 26.48 0.991 0.403 0.33 0.975 0.206 0.981
F2 7.236 0.927 −0.177 0.974 25.86 0.989 0.406 0.32 0.976 0.197 0.979
F3 7.247 0.934 −0.173 0.973 25.84 0.992 0.428 0.30 0.983 0.194 0.980
F4 7.272 0.946 −0.168 0.968 25.77 0.991 0.453 0.28 0.986 0.191 0.980
F5 7.204 0.948 −0.161 0.964 25.46 0.990 0.462 0.27 0.985 0.187 0.978
Table 4 The best fitted model and mechanism of drug release from F1, F2, F3, F4 and F5
Formulation Best fitted model n value Release mechanism
F1 First order, Higuchi, Korsmeyer–Peppas  
and Hixson–Crowell
0.403 Fickian transport
F2 First order, Higuchi, Korsmeyer–Peppas  
and Hixson–Crowell
0.406 Fickian transport
F3 First order, Higuchi, Korsmeyer–Peppas  
and Hixson–Crowell
0.428 Fickian transport
F4 Higuchi, Korsmeyer–Peppas and Hixson–Crowell 0.453 Non-Fickian/anomalous transport





















Fig. 4 Bar diagram representing successive fractional dissolution time of five formulations F1, F2, F3, F4 and 
F5
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of HPMC K100 M CR by 1 mg, T50% increases by 0.0032752 h. Considering the level of 
significance 0.05, P value has been found to be 0.000314 for formulations F1–F5. This 
indicates that, P value is <0.05. So it can be concluded that, the effect of the change in 
the amount of HPMC K 100 M CR on T50% is statistically significant (Fig. 5). 
Table 5 Summary of impact analysis of % drug loading on different formulation parame-
ters of formulations F1–F5 using simple linear regression model (level of significance 0.05)
Formulation parameters Regression coef-
ficient (β)
P value Result Comment
Yield (%) 0.04153 0.10648 P value >0.05 Statistically insignificant
Drug entrapment  
efficiency (%)
0.037828 0.000848 P value <0.05 Statistically significant
Time required for 50 %  
of drug release (T50%)
0.0032752 0.000314 P value <0.05 Statistically significant
Fig. 5 FTIR spectra of a pure Fexofenadine HCl (S6), b HPMC K100 M CR (S3), c physical mixture of Fexofena-
dine HCl and HPMC K100 M CR (S2) and d Fexofenadine HCl microsphere prepared with HPMC K100 M CR 
(F3)
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Fourier transform infrared spectroscopy (FTIR)
FTIR spectra of pure Fexofenadine HCl (S6), physical mixture of Fexofenadine HCl and 
HPMC K100 M CR (S2) and Fexofenadine HCl microspheres prepared with HPMC K100 
M CR (F3) were observed and shown in Fig. 5. The FTIR spectra of pure Fexofenadine HCl 
depict characteristic absorption band at 3364.88, 1707.03, 1464, 1279.79 and 1168.88 cm−1 
which represent the presence of broad, O–H stretching vibrations, carbonyl (C=O) stretch-
ing of Carboxylic acid, aromatic C=C stretching and C–O stretching vibration of tertiary 
alcohol respectively. According to Fig. 5, the FTIR spectra of Fexofenadine HCl loaded micro-
sphere (F3) show characteristic absorption band at 3364.88, 1707.03, 1464, 1279.79, and 
1168.88 cm−1 which represent the presence of broad, O–H stretching vibrations, carbonyl 
(C=O)stretching of carboxylic acid, aromatic C=C stretching and C–O stretching vibration 
of tertiary alcohol respectively (Table 4). It indicates no change of functional groups (Fig. 6).
Differential scanning calorimetric (DSC) study
DSC studies were conducted for pure Fexofenadine HCl, HPMC K100 M CR and their 
physical mixtures and F3 (microspheres of drug prepared with HPMC K100 M CR). The 
data obtained from all of these samples are viewed in Fig. 6 as combined thermogram of 
drug, polymer and microspheres prepared with HPMC K100 M CR. No drastic change 
occurred to the melting point of the microspheres in comparison with pure Fexofenadine 
HCl. So it can be said there is no such incompatibilities in the physical mixture or in the 
microspheres prepared with HPMC K100 M CR in comparison to pure Fexofenadine HCl.
Conclusion
Polymeric microspheres of Fexofenadine HCl were prepared successfully by emulsifica-
tion-solvent evaporation technique using K100 M CR. In this study, it has been demon-
strated that HPMC K100 M CR microspheres containing Fexofenadine HCl can be an 
excellent candidates for consideration in drug delivery system with a sustained effect. As 
the results suggest, F5 can be considered as the best formulation.
Fig. 6 Combined DSC thermogram of pure Fexofenadine HCl, HPMC K100 M CR and their physical mixtures 
and F3 (microspheres of drug prepared with HPMC K100 M CR)
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